Thermo Fisher Scientific Reports First Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
UPDATE: Thermo Fisher Scientific (TMO) Tops Q1 EPS by 15c, Revenues Beat
April 22, 2020 6:02 AM EDT(Updated - April 22, 2020 6:03 AM EDT)
Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $2.94, $0.13 better than the analyst estimate of $2.79. Revenue for the quarter came in at $6.23 billion versus the consensus estimate of $6.17 billion.
First Quarter 2020 Highlights
First quarter revenue increased 2% to $6.23 billion.First quarter GAAP diluted earnings per share (EPS) decreased 2% to $1.97.First quarter adjusted EPS increased 5% to $2.94.Announced agreement to acquire QIAGEN N.V. for $11.5 billion, expanding our specialty diagnostics portfolio with attractive molecular diagnostics capabilities and enhancing our life sciences offering with innovative sample preparation... More